Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer

1 year ago 83

Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.

1. Homepage
2. Breast Cancer
3. Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer